RxDoctor Payments Data

Alicia Campbell, PA

Physician Assistant · Leesburg, VANPI 1841689692

Payments from drug & device makers

$3,779in general payments, 2019–2025

Across 199 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$571
  • Pfizer$557
  • Novartis$357
  • AstraZeneca$330
  • Johnson & Johnson$266
  • E.r. Squibb & Sons, L.L.C.$222
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,779 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$11,085
Medicare patients
92
Services billed
219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban311$430,031
JardianceEmpagliflozin104$151,050
EntrestoSacubitril/Valsartan83$112,234
XareltoRivaroxaban81$101,939
Repatha SureclickEvolocumab70$86,920
FarxigaDapagliflozin Propanediol59$73,505
BrilintaTicagrelor21$21,909
Praluent PenAlirocumab11$16,255
Rosuvastatin Calcium276$5,369
NexletolBempedoic Acid11$5,272
Metoprolol Succinate313$4,789
Valsartan119$3,690
Atorvastatin Calcium276$3,389
Ranolazine ErRanolazine17$2,966
Ezetimibe65$2,268

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$557$430,031311 claims
Boehringer IngelheimJardiance$214$151,050104 claims
NovartisEntresto$357$112,23483 claims
Johnson & JohnsonXarelto$266$101,93981 claims
AstraZenecaFarxiga, Brilinta$330$95,41480 claims
Esperion Therapeutics, Inc.Nexletol$49$5,27211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →